FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
Tomorrow is the first day of fall; kick off cozy season with some tasty fall produce (it’s good for you!). And now, here’s ...
The U.S. Food and Drug Administration on Friday approved the first flu vaccine that comes in the form of a nasal spray and ...
The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages ...
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the ...
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a ...
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...
The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...
3. AstraZeneca staffers detained in China over patient data collection, drug imports: Bloomberg Five current and former employees in AstraZeneca’s oncology division have been detained in China ...